Mysimba is a prescription weight loss treatment designed to support people who are overweight or living with obesity. When combined with a balanced diet and consistent physical activity, these weight loss tablets may help improve long-term weight management. Mysimba contains two active ingredients, naltrexone and bupropion, which work together to reduce appetite, control cravings, and target the brain’s reward system linked to eating habits. By lowering food cravings and “food noise,” it can make it easier to maintain a calorie-controlled diet and achieve sustainable weight loss.
The medication is taken every day, beginning with one tablet daily before gradually increasing the dosage over time to a maximum of four tablets per day.
Clinical studies show that people using Mysimba for weight loss can lose an average of 8.1% of their starting body weight after 56 weeks when paired with lifestyle and behavioral support. As a prescription-only weight loss medication, Mysimba must be obtained through a licensed healthcare provider.
How does Mysimba work?
Mysimba weight loss tablets combine naltrexone and bupropion to act on the areas of the brain responsible for hunger, cravings, and energy balance. By helping to reduce overeating and emotional eating triggers, Mysimba supports healthier eating habits and can contribute to meaningful weight loss when combined with healthy lifestyle changes.
Bupropion is also found in certain antidepressant medications and in Zyban, a treatment commonly prescribed to help people stop smoking. This makes Mysimba different from Orlistat, another weight loss medication that works by limiting the amount of dietary fat absorbed from food.
Is Mysimba effective for weight loss?
Research and clinical trials suggest that Mysimba can be an effective option for weight loss, particularly when paired with behavioral coaching, healthy eating, and exercise. In a 56-week study, participants achieved an average weight loss of 5.4%. Those who also received structured lifestyle support experienced greater results, with average weight loss reaching 8.1% of their initial body weight.
Further analysis of multiple studies found that up to 42% of people taking Mysimba lost at least 5% of their body weight over 56 weeks, while up to 22% achieved weight loss of 10% or more. These findings highlight Mysimba as an effective prescription weight loss treatment for many individuals seeking support with obesity and weight management.








Reviews
There are no reviews yet.